In-vitro diagnostic reagents held classifiable under CTI 3822 0019; tariff description untouched by N/N. 16/2019, 17/2019

CESTAT held that the imported in-vitro diagnostic reagents are correctly classifiable under CTI 3822 0019 as "other diagnostic reagents for medical diagnosis" and not under the residual CTI 3822 0090. The Tribunal found that N/N. 16/2019 and 17/2019 only revised duty rates and did not alter the tariff description under heading 3822, rendering the Commissioner (Appeals)' contrary conclusion factually incorrect. Relying on SC precedent prohibiting the department from changing its stand when earlier orders were accepted for the same appellant, CESTAT allowed the appeal and set aside the impugned order.

---

---

ISSUES PRESENTED AND CONSIDERED

1. Whether the imported "In-Vitro Diagnostic Reagents" are classifiable under Customs Tariff Item (CTI) 3822 0019 as "Other diagnostic reagents" for medical diagnosis, attracting Basic Customs Duty (BCD) at 10%, or under CTI 3822 0090 as "Other" (as treated by the Department), attracting BCD at 30% by reason of origin being the United States of America (USA).

2. Whether the origin-based treatment relied upon by the Department (i.e., classifying all CTI 3822 goods originating from USA under CTI 3822 0090) is supported by the Customs Tariff and Notifications No.16/2019 and No.17/2019, and whether such treatment may be applied where the First Schedule description does not change.

3. Whether the Department, having accepted a prior classification decision in respect of identical goods imported by the same importer in another Commissionerate (Chennai) and accepted that decision on review, can take a different stand in the present appeal (doctrine against "pick and choose" by revenue).

ISSUE-WISE DETAILED ANALYSIS

Issue 1 - Correct classification under CTI 3822 0019 v. CTI 3822 0090

Legal framework: Classification of imported goods is governed by the First Schedule to the Customs Tariff Act, 1975; tariff headings and sub-headings must be read according to their textual description. BCD rates are applied as per applicable Notification(s) specifying rates against serial entries.

Precedent treatment: No direct contrary binding precedent was invoked on the interpretation of CTI 3822 entries; the Tribunal examined departmental practice and an accepted decision in the appellant's other case (Chennai). The Court relied on ordinary rules of tariff interpretation and on the absence of textual amendment to the First Schedule entries.

Interpretation and reasoning: The Court examined the First Schedule and the text of CTI 3822 sub-headings and found that Notifications No.16/2019 and No.17/2019 revised duty rates (raising to 30% for certain entries) but did not change the textual description of tariff entries under chapter 38.22. The Tribunal held that the description of CTI 3822 0090 was not amended to read "All goods originating from USA"; rather, it remains a residual "--- Others" entry in the tariff schedule. Classification must therefore follow the textual descriptions in the First Schedule, not an inferred origin-based re-labeling which is not reflected in the tariff text.

Ratio vs. Obiter: Ratio - classification must be determined by the First Schedule's textual descriptions; where an entry's description is not amended by Notification, origin alone cannot transmute the correct sub-heading. Obiter - discussion of specific product characteristics (diagnostic kits) as supporting classification under 3822 0019 beyond textual matching.

Conclusion: The impugned goods (In-Vitro Diagnostic Reagents / VITEK MS-DS Medical Diagnostic Reagents) are classifiable under CTI 3822 0019. The Assistant Commissioner's reclassification to CTI 3822 0090 based on origin was not supported by the First Schedule wording and is legally incorrect.

Issue 2 - Effect of Notifications No.16/2019 and No.17/2019 and use of origin as classification criterion

Legal framework: Changes to rate of duty are effected by Notifications; however, amendments to duty rates do not, unless expressly stated, alter the First Schedule's tariff item descriptions. Classification for tariff purposes follows the Customs Tariff Act and its First Schedule; notifications altering rates but not item descriptions cannot be read to change classification language.

Precedent treatment: The Tribunal relied on the plain text of the Notifications and the First Schedule; no prior authority was identified that supports treating a rate amendment as an implicit amendment to tariff wording.

Interpretation and reasoning: The Tribunal inspected Notifications No.16/2019 and No.17/2019 and found they increased duty rates and excluded application of a concessional effective BCD rate for certain entries in respect of goods originating from USA, but they did not change the description of CTI 3822 0090 to expressly read "All goods originating from USA." The impugned order's reliance on a departmental printed tariff (BPD's Customs Tariff) depiction purportedly showing "All goods originating to USA" was held factually incorrect. The Tribunal concluded that origin-based higher duty arises from the Notifications' rate provisions, not from an alteration of the tariff entry's textual description; origin may affect rate applicability under a notification, but cannot be read to reclassify goods into a particular sub-heading where the First Schedule text does not so provide.

Ratio vs. Obiter: Ratio - Notifications altering duty rates do not change the First Schedule's descriptions absent express amendment; origin may influence rate applicability but does not alter classification when the tariff text is unamended. Obiter - critique of use of departmental printed tariff extracts as definitive over the First Schedule and Gazetted Notifications.

Conclusion: The Notifications justify application of a higher rate for certain goods originating in USA but do not, by themselves, change the tariff descriptions. The Department's classification rationale premised on an alleged textual change to CTI 3822 0090 is factually and legally unsustainable.

Issue 3 - Preclusion of the Department from adopting a contrary stance where it previously accepted an identical classification (doctrine against "pick and choose")

Legal framework: Established principle that the Revenue cannot adopt inconsistent stands in identical factual/legal situations once an earlier decision has been accepted and not appealed - acceptance of a principle in one case precludes pressing an opposite stance in another; promotes legal certainty and prevents selective litigation by the Department.

Precedent treatment (followed): The Tribunal relied on binding Supreme Court principle (as summarized by the Court) that where the Department accepts a Tribunal/Adjudicatory decision on an issue and lets it become final (by not filing or pursuing an appeal), it cannot thereafter take a different contrary position in another case involving the same question. The Tribunal expressly followed this doctrine as applied in cited authorities.

Interpretation and reasoning: The Tribunal noted that an identical product imported by the same importer was classified under CTI 3822 0019 by the Commissioner (Appeals-I), Chennai, that decision was accepted by the Department upon review and no appeal was filed. Given that acceptance, the Tribunal held the Department cannot now adopt an opposite classification in the present proceedings. The Tribunal treated the Chennai decision and its acceptance on review as determinative of the Department's right to re-lodge a contrary stance in the current matter.

Ratio vs. Obiter: Ratio - The Department is precluded from taking a different stand on identical classification issues where a prior decision has been accepted on review and not appealed; such prior acceptance binds the Department and militates against inconsistent classification attempts. Obiter - reinforcement of policy reasons (certainty and administrative consistency).

Conclusion: The Department's attempt to classify the same goods differently in this Commissionerate is impermissible in view of its prior acceptance of the identical classification in Chennai; this supports allowing the appeal and setting aside the impugned order.

Overall Conclusion and Disposition

Based on the textual reading of the First Schedule and the Notifications, and applying the doctrine preventing the Department from taking inconsistent positions where it has previously accepted a contrary classification, the Tribunal concluded that the imported In-Vitro Diagnostic Reagents are classifiable under CTI 3822 0019. The impugned order upholding classification under CTI 3822 0090 is legally unsustainable and is set aside with consequential reliefs, if any, as per law.

---